4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-21-000089
President and CEO sold 18,333 shares at an average $54.66 ($1,002,012)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-09-01 | Sale : show line 1 in the form | −7,441 | $54.27 | $403,823 | 2,169,259 | I |
| 2021-09-01 | Sale : show line 2 in the form | −10,892 | $54.92 | $598,189 | 2,158,367 | I |
| Open-market sales · 18,333 sh · avg $54.66 · $1,002,012 | ||||||
Loading xslF345X03/wf-form4_163066639800542.xml…